MIT engineers have developed a new type of ingestible capsule that can send a signal from inside the stomach to confirm that a medication has been swallowed. The technology is designed to address a long‑standing challenge in medicine: ensuring that patients take their medications consistently and on schedule. Poor adherence is a major barrier to effective treatment for many conditions, including chronic infections and diseases that require strict dosing routines. The MIT team created a system that works within the familiar format of a standard pill capsule while adding a simple way to verify ingestion in real time. The capsule…

Researchers at the University of Arizona have developed a soft, comfortable wearable device that uses artificial intelligence to detect early signs of frailty, a condition that significantly increases the risk of falls, hospitalization, and loss of independence among older adults and people with disabilities. Frailty is common but often underdiagnosed because it is usually assessed only after a major adverse event has already occurred. The team’s goal is to shift care from reactive to preventative by enabling continuous monitoring in everyday life. The device takes the form of a soft mesh sleeve worn around the lower thigh. It continuously monitors…

Researchers at the University of Mississippi are advancing a new drug delivery system based on smart capsules that can release medication in a controlled and programmable way. The goal is to make treatments more effective while reducing the burden on patients who require long‑term therapies. The technology is designed to address a common problem in chronic disease care: patients often need to take multiple doses of medication each day, which can be difficult to manage consistently. Missed doses or irregular drug levels can reduce the effectiveness of treatment and increase side effects. Smart capsules aim to solve this by automating…

Glioblastoma is one of the most aggressive brain cancers, with most patients dying within two years and only about 10 percent surviving five years. Surgery cannot remove all tumor cells because they infiltrate brain tissue, and most chemotherapy drugs cannot cross the blood‑brain barrier. This makes monitoring treatment effectiveness especially difficult. Researchers at Northwestern Medicine and the University of Michigan have shown that a simple blood draw can reveal whether chemotherapy is killing glioblastoma cells. In a clinical trial, Northwestern doctors used the SonoCloud‑9 ultrasound device, developed by Carthera in France, to temporarily open the blood‑brain barrier for about an…

Head and neck cancers that invade bone are among the most difficult to treat surgically, because surgeons must balance complete tumor removal with preserving critical functions like speech, chewing, and swallowing. At The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, researchers have shown that patient‑specific 3D‑printed models can improve this balance. In a study of 68 patients, 37 surgeries used custom 3D models created by the Medical Modeling, Materials and Manufacturing Lab. These models provided surgeons with a detailed, tangible guide to the patient’s anatomy and tumor location. The…

A team at the University of Colorado, Boulder has introduced a novel cancer treatment approach that uses ultrasound waves to soften tumors, enabling chemotherapy drugs to penetrate more effectively. Cancer remains the second leading cause of death in the United States, and one of the challenges in treatment is that tumor tissue is often so dense that drugs cannot reach the inner layers of cancer cells. The CU Boulder researchers paired high‑frequency ultrasound with specially designed particles that respond to sound waves. This combination reduced the protein content of tumors, loosening their structure and allowing chemotherapy agents to spread more…

Researchers at Harvard University John A. Paulson School of Engineering and Applied Sciences and the Department of Stem Cell and Regenerative Biology have developed soft electronic cardiac patches that integrate nanoelectronics with stem cell–derived heart tissue. The goal is to improve the safety and effectiveness of stem cell therapies for repairing damaged hearts. Stem cell–derived cardiomyocytes hold promise for regenerating heart tissue after injury, but a major challenge has been their tendency to cause irregular rhythms when transplanted. Until now, clinicians have lacked tools to monitor how these cells behave once inside the heart. The Harvard team’s new platform embeds…

An interdisciplinary team from Dresden University of Technology, Rostock University Medical Centre, and Dresden University Hospital has introduced an innovative implantable sensor film that enables reliable early detection of blood flow disorders following intestinal surgery. These disorders, particularly at intestinal anastomoses where sections of the bowel are surgically reconnected, represent one of the highest‑risk complications in abdominal surgery. The newly developed sensor film is both implantable and fully resorbable, meaning it dissolves naturally in the body after use. This eliminates the need for removal procedures and reduces the risk of long‑term complications. By continuously monitoring blood supply at the surgical…

Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed an implantable, shape‑morphing 3D micro‑LED device designed to overcome barriers in pancreatic cancer treatment. Conventional therapies are limited by the dense tumor microenvironment, which blocks drugs and immune cells, while external lasers used in photodynamic therapy cannot penetrate deep tissue and risk damaging healthy organs. The new device uses a flexible, octopus‑like architecture that wraps around the tumor, maintaining uniform light delivery even as the tissue expands or contracts. This enables continuous, low‑intensity photostimulation that targets cancer cells while preserving normal tissue. In in vivo mouse experiments, the technology…

Georgia Tech engineers have created a soft, all‑in‑one wearable system designed to improve neonatal health monitoring in low‑resource settings. The device combines a chest‑mounted patch with a forehead‑mounted pulse oximeter, transmitting real‑time data on heart rate, respiration, temperature, electrocardiograms, and blood oxygen saturation to a smartphone app. By automating vital sign tracking, the system reduces reliance on handwritten records and limited medical equipment, enabling faster detection of dangerous changes in newborns. A pilot study at Tikur Anbessa Specialized Hospital in Addis Ababa, Ethiopia, conducted with Ethiopian collaborators, showed that the wearable system provided superior oversight compared to current monitoring practices.…